Details for New Drug Application (NDA): 204441
✉ Email this page to a colleague
The generic ingredient in JYNARQUE is tolvaptan. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the tolvaptan profile page.
Pharmacology for NDA: 204441
Mechanism of Action | Vasopressin V2 Receptor Antagonists |
Suppliers and Packaging for NDA: 204441
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
JYNARQUE | tolvaptan | TABLET;ORAL | 204441 | NDA | Otsuka America Pharmaceutical, Inc. | 59148-079 | 59148-079-28 | 4 BLISTER PACK in 1 CARTON (59148-079-28) / 1 KIT in 1 BLISTER PACK (59148-079-07) |
JYNARQUE | tolvaptan | TABLET;ORAL | 204441 | NDA | Otsuka America Pharmaceutical, Inc. | 59148-080 | 59148-080-28 | 4 BLISTER PACK in 1 CARTON (59148-080-28) / 1 KIT in 1 BLISTER PACK (59148-080-07) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 15MG | ||||
Approval Date: | Apr 23, 2018 | TE: | RLD: | Yes | |||||
Regulatory Exclusivity Expiration: | Apr 23, 2025 | ||||||||
Regulatory Exclusivity Use: | INDICATED TO SLOW KIDNEY FUNCTION DECLINE IN ADULTS AT RISK OF RAPIDLY PROGRESSING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Apr 7, 2030 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 1, 2026 | Product Flag? | Substance Flag? | Y | Delist Request? |
Expired US Patents for NDA 204441
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Otsuka | JYNARQUE | tolvaptan | TABLET;ORAL | 204441-003 | Apr 23, 2018 | ⤷ Sign Up | ⤷ Sign Up |
Otsuka | JYNARQUE | tolvaptan | TABLET;ORAL | 204441-001 | Apr 23, 2018 | ⤷ Sign Up | ⤷ Sign Up |
Otsuka | JYNARQUE | tolvaptan | TABLET;ORAL | 204441-005 | Apr 23, 2018 | ⤷ Sign Up | ⤷ Sign Up |
Otsuka | JYNARQUE | tolvaptan | TABLET;ORAL | 204441-004 | Apr 23, 2018 | ⤷ Sign Up | ⤷ Sign Up |
Otsuka | JYNARQUE | tolvaptan | TABLET;ORAL | 204441-004 | Apr 23, 2018 | ⤷ Sign Up | ⤷ Sign Up |
Otsuka | JYNARQUE | tolvaptan | TABLET;ORAL | 204441-002 | Apr 23, 2018 | ⤷ Sign Up | ⤷ Sign Up |
Otsuka | JYNARQUE | tolvaptan | TABLET;ORAL | 204441-002 | Apr 23, 2018 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription